US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,738.19

+0.50560.03%

Number of Gainers:4

Number of Losers:15

Number of Flat:- -

PE:- -

High:1,763.41

Open:1,739.02

Low:1,736.63

Close:1,737.68

Volume:80.50M

Turnover:5.58B

Market Cap:1.42T

Float Cap:1.40T

Loading ...

Ocugen Reports Positive Phase 2 Trial Data For Eye Disease Therapy

MT Newswires Live

Aethlon Medical advances to final cohort in AEMD-2022-06 trial

Aethlon Medical opens final cohort in Hemopurifier oncology trial after DSMB review finds no safety concerns

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive Dsmb Review

THOMSON REUTERS

Aethlon Medical Inc: Dsmb Also Stated That "No Safety Concerns Were Noted With Hemopurifier Device/Procedure"

THOMSON REUTERS

BUZZ- Ocugen rises as gene therapy slows vision loss in advanced eye disease trial

Ocugen announces 12-month data from ArMaDa clinical trial of OCU410

Ocugen reports 31% lesion growth reduction at 12 months in Phase 2 ArMaDa trial of OCU410 for geographic atrophy

Ocugen Inc - to Initiate Ocu410 Phase 3 Registrational Trial in Q3 2026

THOMSON REUTERS

Ocugen Announces Topline 12-Month Data From Phase 2 Armada Clinical Trial Evaluating Ocu410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

THOMSON REUTERS

Ocugen Inc - No Serious Adverse Events Related to Ocu410 Reported to Date

THOMSON REUTERS

Pfizer Is Maintained at Buy by Guggenheim

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pfizer (PFE) and Wave Life Sciences (WVE)

Citi Remains a Hold on Pfizer (PFE)

Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Idexx Laboratories (IDXX)

Guggenheim Adjusts Pfizer's PT to $36 From $35, Keeps Buy Rating

MT Newswires Live

U.S. Stocks to Watch: Tesla, Jefferies, Apollo, Gilead, Estée Lauder, and More

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Xencor (XNCR)

Deals of the day-Mergers and acquisitions

PRESS DIGEST -Wall Street Journal - March 24

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1738.1877,"timestamp":1774641599999,"preClose":1737.6821,"halted":0,"volume":80495097,"delay":0,"changeRate":0.000291,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":0.505615,"latestTime":"03-27 16:00:00 EDT","open":1739.0173,"high":1763.4143,"low":1736.6282,"amount":5580813523.057932,"amplitude":0.015415,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.394763,"peRate":25.653916,"turnoverRate":0.005815,"increases":4,"decrements":15,"flats":0,"marketCap":1418680037191.25,"floatMarketCap":1399640416814.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1763.4143,"amplitude":0.015415,"preClose":1737.6821,"low":1736.6282,"pbRate":"4.394763","latestPrice":1738.1877,"volume":80495097,"delay":0,"open":1739.0173,"prevYearClose":1637.1339,"prevWeekClose":1724.4738,"prevMonthClose":1860.0614,"prevQuarterClose":1637.1339,"fiveDayClose":1724.4738,"twentyDayClose":1860.0614,"sixtyDayClose":1642.1692,"secType":"PLATE","market":"US","turnoverRate":0.005815,"peRate":25.653916,"marketCap":1418680037191.25,"floatMarketCap":1399640416814.25,"timestamp":1774641599999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":4,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621502062","title":"Ocugen Reports Positive Phase 2 Trial Data For Eye Disease Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2621502062","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621502062?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:29","pubTimestamp":1774355353,"startTime":"0","endTime":"0","summary":"Ocugen  said Tuesday that its experimental gene therapy showed a 31% reduction in lesion growth compared with a control group in a phase 2 clinical trial for a dry age-related macular degeneration treatment.The 12-month results evaluating the medium dose of the candidate showed a 27% slower rate of structural loss among patients with geographic atrophy, the company said.The treatment maintained a safety profile with no serious adverse events or related complications reported during the study, Ocugen said.The company also said it expects to start a phase 3 registrational trial for the therapy in Q3.Shares of the company were down by more than 10% in Tuesday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","OCGN","BK4563","BK4139"],"gpt_icon":0},{"id":"2621064201","title":"Aethlon Medical advances to final cohort in AEMD-2022-06 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2621064201","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621064201?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:11","pubTimestamp":1774354290,"startTime":"0","endTime":"0","summary":"Aethlon Medical (AEMD) announced that the independent Data Safety Monitoring Board overseeing its ongoing clinical trial AEMD-2022-06 has completed...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aethlon-medical-advances-to-final-cohort-in-aemd-2022-06-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aethlon-medical-advances-to-final-cohort-in-aemd-2022-06-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4082","AEMD","BK4583"],"gpt_icon":0},{"id":"2621646470","title":"Aethlon Medical opens final cohort in Hemopurifier oncology trial after DSMB review finds no safety concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2621646470","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621646470?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:04","pubTimestamp":1774353896,"startTime":"0","endTime":"0","summary":"Aethlon Medical said its independent Data Safety Monitoring Board reviewed safety data from the second cohort of clinical trial AEMD-2022-06 and recommended advancing to the third and final cohort.The study is evaluating the safety, feasibility, and dose-finding of the Hemopurifier device in patients with solid tumors receiving pembrolizumab or nivolumab.In Cohort 2, participants received 2 Hemopurifier treatments over 1 week, and the company reported no serious adverse events or dose-limiting toxicities related to the device or treatment to date.Cohort 3 enrollment is open, with participants planned to receive 3 treatments over 1 week at 3 clinical sites in Australia.The company said the study is designed to enroll about 9 to 18 patients and that a final data set and clinical study report will be prepared in the future.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL3K82sw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","AEMD","BK4583"],"gpt_icon":0},{"id":"2621064536","title":"Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive Dsmb Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2621064536","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621064536?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:04","pubTimestamp":1774353875,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C0MQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AEMD","BK4082","BK4583","BK4568"],"gpt_icon":0},{"id":"2621064522","title":"Aethlon Medical Inc: Dsmb Also Stated That \"No Safety Concerns Were Noted With Hemopurifier Device/Procedure\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2621064522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621064522?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:04","pubTimestamp":1774353875,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C0MQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","AEMD","BK4583","BK4082"],"gpt_icon":0},{"id":"2621406173","title":"BUZZ- Ocugen rises as gene therapy slows vision loss in advanced eye disease trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2621406173","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621406173?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:58","pubTimestamp":1774353539,"startTime":"0","endTime":"0","summary":"BUZZ- Ocugen rises as gene therapy slows vision loss in advanced eye disease trial** Shares of biotech firm Ocugen OCGN.O rise 4.2% to $2.19 premarket** Co says its experimental gene therapy slowed disease progression in geographic atrophy, an advanced eye condition that causes vision loss in older people** Mid-stage trial showed OCU410 cut growth of vision-damaging eye lesions by 31% over 12 months, co says** Co compares result with about 15% reduction at 12 months and 22% at 24 months seen with approved treatments, which need frequent eye injections ** No serious side effects linked to the one-time treatment were reported, co says** Says it plans larger late-stage trial later this year and aims to seek regulatory approval within three years** Shares rose ~68% in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL4N40C0ZA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","OCGN","BK4139","BK4563"],"gpt_icon":0},{"id":"2621061099","title":"Ocugen announces 12-month data from ArMaDa clinical trial of OCU410","url":"https://stock-news.laohu8.com/highlight/detail?id=2621061099","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621061099?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:55","pubTimestamp":1774353327,"startTime":"0","endTime":"0","summary":"Ocugen (OCGN) announced 12-month data from the Phase 2 ArMaDa clinical trial evaluating OCU410, its modifier gene therapy for geographic atrophy se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ocugen-announces-12-month-data-from-armada-clinical-trial-of-ocu410-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ocugen-announces-12-month-data-from-armada-clinical-trial-of-ocu410-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OCGN","BK4139","BK4563","BK4568"],"gpt_icon":0},{"id":"2621061181","title":"Ocugen reports 31% lesion growth reduction at 12 months in Phase 2 ArMaDa trial of OCU410 for geographic atrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2621061181","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621061181?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:45","pubTimestamp":1774352719,"startTime":"0","endTime":"0","summary":"Ocugen reported topline 12-month results from the Phase 2 ArMaDa trial of OCU410 , a single subretinal gene therapy being studied for geographic atrophy secondary to dry age-related macular degeneration.In the medium-dose group, the study showed a 31% reduction in geographic atrophy lesion growth versus control at 12 months .Safety findings reported to date included no OCU410-related serious adverse events and no cases of endophthalmitis, retinal detachment, vasculitis, choroidal neovascularization, or ischemic optic neuropathy.The Phase 2 trial randomized 51 patients 1:1:1 to medium dose, high dose, or no treatment control.Ocugen said it plans to initiate a Phase 3 registrational trial in the third quarter of 2026 with up to 300 subjects.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL83F02Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","LU0314104364.USD","OCGN","SG9999014013.SGD","IE00BKPKM429.USD","NDAQ","SG9999014005.SGD","BK4585","IE00BN0W2V16.EUR","BK4563","BK4112","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4139","BK4568","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4588"],"gpt_icon":0},{"id":"2621977061","title":"Ocugen Inc - to Initiate Ocu410 Phase 3 Registrational Trial in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621977061","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621977061?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:45","pubTimestamp":1774352700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA9ZGKVK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCGN","BK4568","BK4139","BK4563"],"gpt_icon":0},{"id":"2621619740","title":"Ocugen Announces Topline 12-Month Data From Phase 2 Armada Clinical Trial Evaluating Ocu410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration","url":"https://stock-news.laohu8.com/highlight/detail?id=2621619740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621619740?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:45","pubTimestamp":1774352700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA9ZGKVK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","OCGN","BK4139","BK4568"],"gpt_icon":0},{"id":"2621061979","title":"Ocugen Inc - No Serious Adverse Events Related to Ocu410 Reported to Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2621061979","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621061979?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:45","pubTimestamp":1774352700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA9ZGKVK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCGN","BK4563","BK4568","BK4139"],"gpt_icon":0},{"id":"2621061188","title":"Pfizer Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2621061188","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621061188?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:44","pubTimestamp":1774352640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PFE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2026 07:44 ET (11:44 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","IE00BLSP4452.SGD","BK4568","LU0985481810.HKD","IE00BLSP4239.USD","IE0002270589.USD","LU1894683348.USD","SGXZ57979304.SGD","LU1883839398.USD","LU0868494617.USD","IE00B19Z3581.USD","SG9999013999.USD","LU1057294990.SGD","LU0321505439.SGD","LU0321505868.SGD","BK4581","BK4592","SG9999001176.SGD","BK4550","SG9999002224.SGD","LU0289739699.SGD","LU0170899867.USD","BK4588","BK4585","LU1894683264.USD","SG9999011175.SGD","BK4599","LU0456855351.SGD","LU1066053197.SGD","IE00BBT3K403.USD","BK4534","LU0122379950.USD","BK4533","IE000M9KFDE8.USD","LU0306806265.USD","SG9999003800.SGD","LU0058720904.USD","LU0225771236.USD","LU0306807586.USD","LU1066051498.USD","PFE","LU0225284248.USD","LU0234572021.USD","SG9999002232.USD","SG9999001176.USD","IE00B19Z3B42.SGD","BK4007"],"gpt_icon":0},{"id":"2621106163","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pfizer (PFE) and Wave Life Sciences (WVE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621106163","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621106163?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:30","pubTimestamp":1774351805,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abbott Laboratories (ABT), Pfizer (PFE) and Wave Life Sciences (W...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-pfizer-pfe-and-wave-life-sciences-wve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-pfizer-pfe-and-wave-life-sciences-wve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2112291526.USD","BK4550","LU0456855351.SGD","SG9999001176.USD","LU1883839398.USD","LU2237957811.SGD","LU0306807586.USD","LU1721429402.USD","BK4566","IE0009355771.USD","LU0058720904.USD","LU0170899867.USD","LU2133065610.SGD","LU0029874061.USD","LU0114720955.EUR","LU0321505868.SGD","LU1691799644.USD","BK4082","IE00B19Z3581.USD","LU0128526141.USD","BK4007","LU2237957902.USD","LU1057294990.SGD","IE0002270589.USD","LU2324357040.USD","LU1023059063.AUD","IE00BLSP4239.USD","WVE","LU2468319806.SGD","LU0234572021.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU1721429741.USD","BK4581","IE00B4R5TH58.HKD","BK4588","IE00BLSP4452.SGD","LU1066053197.SGD","LU1989763427.SGD","BK4599","LU0306806265.USD","LU0225771236.USD","LU1066051498.USD","IE00B19Z3B42.SGD","LABU","BK4585","LU1894683348.USD","BK4504","SG9999002224.SGD","LU1989763690.USD","SG9999001176.SGD","BK4592","XBI","LU1894683264.USD","LU1061106388.HKD","LU0225284248.USD","LU0882574055.USD","IE0002141913.USD","LU0266013472.USD","BK4533","BK4568","LU2089984988.USD","SG9999004303.SGD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","SG9999002232.USD","LU2211815571.USD","SGXZ23171101.USD","SGXZ41872573.SGD","IE00BFTCPJ56.SGD","SG9999013999.USD","SGXZ57979304.SGD","LU0868494617.USD","LU0985481810.HKD","PFE","LU0321505439.SGD","SG9999003800.SGD","BK4534","LU0122379950.USD","IE00BBT3K403.USD","SG9999011175.SGD","LU1914381329.SGD","ABT","IE00BJJMRZ35.SGD","BK4137"],"gpt_icon":0},{"id":"2621069608","title":"Citi Remains a Hold on Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621069608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621069608?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:16","pubTimestamp":1774350986,"startTime":"0","endTime":"0","summary":"In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer, with a price target of $26.00. Meacham covers the Healthcar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1066051498.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU0234572021.USD","SG9999003800.SGD","SG9999002232.USD","BK4585","BK4568","LU0122379950.USD","BK4592","SG9999001176.USD","IE00BLSP4452.SGD","SG9999013999.USD","SGXZ57979304.SGD","SG9999011175.SGD","IE00BLSP4239.USD","BK4581","LU1023059063.AUD","LU0058720904.USD","LU0289739699.SGD","IE00BBT3K403.USD","BK4533","LU0170899867.USD","SG9999001176.SGD","SG9999002224.SGD","LU0321505439.SGD","BK4599","LU0306807586.USD","LU1894683264.USD","LU0225284248.USD","BK4588","LU0321505868.SGD","LU0868494617.USD","LU0306806265.USD","LU0985481810.HKD","LU1883839398.USD","LU1057294990.SGD","BK4534","LU1066053197.SGD","LU0225771236.USD","PFE","BK4550","LU1894683348.USD","LU0456855351.SGD"],"gpt_icon":0},{"id":"2621066444","title":"Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621066444?lang=en_us&edition=fundamental","pubTime":"2026-03-24 18:50","pubTimestamp":1774349440,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE) and Idexx Laboratories (IDXX). Pfizer (PFE) Jefferie...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505868.SGD","LU0306807586.USD","LU1023059063.AUD","SG9999003800.SGD","LU0234572021.USD","LU0690374615.EUR","BK4567","LU0058720904.USD","LU2404859667.USD","XBI","SG9999002232.USD","SG9999002224.SGD","BK4007","LU1989771016.USD","IE00BBT3K403.USD","GB00B4QBRK32.GBP","LABU","LU0225284248.USD","LU0690374961.EUR","BK4137","LU0985481810.HKD","LU0122379950.USD","LU1066051498.USD","LU1066053197.SGD","LU0029874061.USD","BK4534","IE00BLSP4452.SGD","BK4533","LU1291159041.SGD","LU2404859741.USD","SG9999001176.USD","LU0306806265.USD","BK4581","LU0289739699.SGD","SG9999013999.USD","BK4550","LU0170899867.USD","LU0868494617.USD","BK4568","BK4585","LU0456855351.SGD","SG9999011175.SGD","BK4592","IE00B19Z3581.USD","IE0002270589.USD","LU0345774391.USD","BK4082","LU0321505439.SGD","BK4599","LU1057294990.SGD","LU0345774631.USD","BK4504","SG9999001176.SGD","BK4588","LU1894683264.USD","GB00B4LPDJ14.GBP","IDXX","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0225771236.USD","LU1941712348.USD","LU1941712264.USD","LU1883839398.USD","PFE","LU1894683348.USD","SGXZ57979304.SGD","LU0128526141.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2621699065","title":"Guggenheim Adjusts Pfizer's PT to $36 From $35, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2621699065","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621699065?lang=en_us&edition=fundamental","pubTime":"2026-03-24 18:28","pubTimestamp":1774348124,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) has an average rating of hold and mean price target of $28.48, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1023059063.AUD","LU1057294990.SGD","LU1066053197.SGD","SG9999001176.USD","LU1894683348.USD","BK4007","BK4592","LU0122379950.USD","IE00BBT3K403.USD","BK4585","IE00B19Z3581.USD","LU0058720904.USD","LU0225771236.USD","BK7095","IE000M9KFDE8.USD","SG9999001176.SGD","SG9999013999.USD","BK4533","BK4588","LU0306806265.USD","LU0321505868.SGD","PFE","BK4550","BK4581","BK4599","LU0456855351.SGD","LU0321505439.SGD","BK4534","LU0234572021.USD","SGXZ57979304.SGD","SG9999002224.SGD","SG9999011175.SGD","LU0170899867.USD","LU0868494617.USD","LU1066051498.USD","IE0002270589.USD","LU1883839398.USD","LU0306807586.USD","LU0289739699.SGD","SG9999003800.SGD","LU0225284248.USD","SG9999002232.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4568","LU1894683264.USD"],"gpt_icon":0},{"id":"2621637450","title":"U.S. Stocks to Watch: Tesla, Jefferies, Apollo, Gilead, Estée Lauder, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2621637450","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621637450?lang=en_us&edition=fundamental","pubTime":"2026-03-24 18:24","pubTimestamp":1774347887,"startTime":"0","endTime":"0","summary":"Stock futures were sliding Tuesday as investors worried that the war in Iran could drag on, even though President Donald Trump said on Monday that the U.S. and Iran had started peace talks.These...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLP","LU1267930730.SGD","LU0234572021.USD","LU1674673691.USD","LU1429558221.USD","LU2750360997.AUD","IE00B1BXHZ80.USD","LU2326559502.SGD","TSLZ","BK4543","LU0114720955.EUR","LU0316494557.USD","IE0034235303.USD","LU0719512351.SGD","LU0210536198.USD","LU1861220033.SGD","LU0943347566.SGD","BK4516","LU1934455277.USD","LU2471134523.USD","IE00BKVL7J92.USD","IE00B19Z8W00.USD","LU1366192091.USD","BK4550","IE00BJLML261.HKD","LU0082616367.USD","LU0689472784.USD","LU0320765992.SGD","IE00BWXC8680.SGD","LU1066051225.USD","LU1778281490.HKD","LU1629891620.HKD","LU2552382215.SGD","LU0345770308.USD","IE00B19Z8X17.USD","TSL","IE00B775SV38.USD","LU2249611893.SGD","TESL","LU1551013425.SGD","TLA","LU0345769631.USD","LU0320765059.SGD","BK4588","LU1548497426.USD","IE00B19Z3B42.SGD","LU0965509283.SGD","07766","TSLT","LU0965509101.SGD","BK4548","TSLL","BK4559","LU0109391861.USD","SG9999015978.USD","LU2213496289.HKD","LU0690374615.EUR","BK4612","LU2404859667.USD","LU2456880835.USD","LU0345770993.USD","BK4511","TSLO","LU0122379950.USD","LU1066051498.USD","LU1861559042.SGD","LU1585245621.USD","LU2403377893.USD","LU0965509010.AUD","LU2750360641.GBP","IE00B7SZLL34.SGD","LU0820561818.USD","LU0964807845.USD","LU2404859741.USD","CRSH","BK4581","LU0965508806.USD","LU2290526834.HKD","LU0672654240.SGD","LU2108987350.USD","LU2468319806.SGD","SG9999015945.SGD","BK4532","LU2112291526.USD","LU2360106780.USD","LU0348723411.USD","TSLG","LU1066051811.HKD","LU2357305700.SGD","LU0077335932.USD","LU0823411888.USD","LU1914381329.SGD","TSLY","LU1551013342.USD","TSLQ","IE0002270589.USD","IE00BK4W5L77.USD","LU0198837287.USD","LU2471134879.HKD","IE00BZ1G4Q59.USD","LU0820562030.AUD","IE00BK4W5M84.HKD","LU2324357040.USD","GME","LU1037948541.HKD","LU0820561909.HKD","LU2471134952.CNY","LU2896262040.SGD","LU0787776722.HKD","BK4598","BK4551","LU0889565916.HKD","GILD","LU1037948897.HKD","LU2250418816.HKD","TSDD","LU2417539215.USD","LU1145028129.USD","LU0109394709.USD","LU0683600562.USD","BK4583","LU1066053197.SGD","LU0053666078.USD","BK4604","LU2552382058.USD","LU1674673428.USD","LU0289739699.SGD","TSLR","BK4127","LU0861579265.USD","LU0006061336.USD","JEF","IE00B3T34201.USD","LU0106831901.USD","LU0323591593.USD","IE00B1XK9C88.USD","LU1720051017.SGD","LU2756315318.SGD","TSYY","LU1934455194.USD","LU1861215975.USD","BK4527","BK4135","LU2089984988.USD","BK4504","LU2602419157.SGD","TSLA","SG9999015952.SGD","BK4566","LU2471134796.USD","LU1720051108.HKD","EL","BK4183","BK4139","LU2236285917.USD","LU1232071149.USD","BK4558","LU1023059063.AUD","IE00BSNM7G36.USD","BK4578","LU0058720904.USD","TSLW","LU1668664300.SGD","LU2063271972.USD","LU1791807156.HKD","SG9999015986.USD","LU0690374961.EUR","BK4555","LU0466842654.USD","LU0882574055.USD","TSII","LU2462157665.USD","BK4534","BK4533","LU1061106388.HKD","APO","BK4574","LU1323610961.USD","LU0345769128.USD","LU2360107168.USD","LU0097036916.USD","LU2023250330.USD","LU0056508442.USD","TSLI","LU1934455863.HKD","TEST","BK4568","LU0708995401.HKD","LU0823414478.USD","BK4585","LU0234570918.USD","TSLS","BK4592","IE00B19Z3581.USD","LU2756315664.SGD","LU2420271590.USD","LU1057294990.SGD","LU2087621335.USD","IE00B19Z9505.USD","LU1430594728.SGD","LU1571399168.USD","LU2552382132.HKD","LU1839511570.USD","LU0823416689.USD","BK4184","BK4099","LU1435385759.SGD","LU1861558580.USD","LU1852331112.SGD","IE00B3S45H60.SGD"],"gpt_icon":1},{"id":"2621065395","title":"Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Xencor (XNCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621065395","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621065395?lang=en_us&edition=fundamental","pubTime":"2026-03-24 18:10","pubTimestamp":1774347016,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Moderna (MRNA) and Xencor (XNCR). Moderna (MRNA) I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-moderna-mrna-and-xencor-xncr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-moderna-mrna-and-xencor-xncr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","MRNY","BK4534","BK4533","MRNA","BK4581","LU0029874061.USD","BK4588","BK4548","BK4568","BK4585","XBI","BK4139","BK4551","MRNX","BK4137","BK4532","XLV","XNCR","HCSG","BK4501","LABU"],"gpt_icon":0},{"id":"2621068107","title":"Deals of the day-Mergers and acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2621068107","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621068107?lang=en_us&edition=fundamental","pubTime":"2026-03-24 17:35","pubTimestamp":1774344903,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsMarch 24 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Tuesday:** State-backed Poste Italiane <PST.MI> has m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL6N40C0JY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1023061473.USD","LU0889565916.HKD","LU0211328371.USD","LU1778281490.HKD","SG9999001135.SGD","IE00B3T34201.USD","LU1057294990.SGD","LU0526926950.USD","BK4175","LU1201861165.SGD","LU0122379950.USD","IE00B7SZLL34.SGD","LU0077335932.USD","LU1242518857.USD","LU2089984988.USD","BK4022","IE00BZ1G4Q59.USD","COR","LU0648000940.SGD","LU0823416689.USD","LU0575583348.USD","LU1585245621.USD","BK4019","LU0532188223.SGD","LU0441851309.USD","LU1814569148.SGD","LU0289739699.SGD","SG9999015986.USD","LU2362541273.HKD","BK4568","IE00BSNM7G36.USD","SGXZ23171101.USD","IE00BKVL7J92.USD","LU0320765992.SGD","LU1430594728.SGD","LU1934455194.USD","LU0861579265.USD","LU0965509101.SGD","LU1302929846.USD","LU1066053197.SGD","BK4529","GILD","LU0171293334.USD","LU1880407215.USD","SG9999013460.SGD","LU0171280430.USD","BRK.A",".IXIC","LU1119994496.HKD","LU0310800965.SGD","BK4122","LU0971552673.USD","LU1934455277.USD","SG9999006266.SGD","LU0971552830.HKD","LU0106831901.USD","BK4127","BK4550","BK4230","LU1023061713.HKD","SG9999002604.SGD","LU1037948541.HKD","LU1261432733.SGD","LU0965509283.SGD","LU0171281750.USD","LU2362541513.USD","SG9999002406.SGD","LU1267930227.SGD","BK5152","SGXZ58947870.SGD","LU0210637038.USD","LU2125910500.SGD","LU1880407132.USD","LU1061106388.HKD","JEF","LU0963555726.SGD","LU1046248800.SGD","BK4583","LU2045819591.USD","LU0052756011.USD","LU2237957902.USD","LU0882574055.USD","SG9999002414.USD","LU0109394709.USD","LU0788108743.HKD","BK4139","BK4566","LU1196525536.USD","BK4084","LU0477156797.USD","BK4585","LU0128525689.USD","SG9999004303.SGD","LU1015430645.USD","BK4559","LU1084165304.USD","LU2112291526.USD","EG","LU0130518102.USD","LU1037948897.HKD","LU1267930490.SGD","LU0058720904.USD","IE00B19Z3581.USD","LU0234570918.USD","LU1839511570.USD","LU1242518931.SGD","SG9999013478.USD","LU2324357040.USD","LU0965509010.AUD","LU0769137737.USD","BK4578","GRAB","LU0211327993.USD","BK4532","SG9999002620.SGD","LU2468319806.SGD","LU0211331839.USD","LU0130103400.USD","LU1023059063.AUD","LU1674673691.USD","LU1571399168.USD","LU1668664300.SGD","LU1934455863.HKD","LU1066051498.USD","LU2237957811.SGD","IE0002270589.USD","SG9999015978.USD","LU1674673428.USD","LU0979878070.USD","LU2087621335.USD","SG9999013486.USD","LU0310799852.SGD","LU2362540622.SGD","SG9999015945.SGD","LU0965508806.USD","LU1839390173.USD","SG9999002679.SGD","IE00B19Z3B42.SGD","SG9999015952.SGD","LU0114720955.EUR"],"gpt_icon":1},{"id":"2621556430","title":"PRESS DIGEST -Wall Street Journal - March 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2621556430","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621556430?lang=en_us&edition=fundamental","pubTime":"2026-03-24 14:18","pubTimestamp":1774333109,"startTime":"0","endTime":"0","summary":"PRESS DIGEST -Wall Street Journal - March 24March 24 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL4N40C0EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU0545562505.USD","LU0056508442.USD","LU0965508806.USD","BK4099","IE0004445015.USD","LU0348723411.USD","TSLZ","LU0079474960.USD","LU0347712357.USD","LU1989764748.USD","SG9999014914.USD","LU2746668974.SGD","BK4587","LU2065169927.USD","LU1974910355.USD","LU1934455277.USD","LU2286300806.USD","LU2125154778.USD","LU1721428933.USD","LU0061475181.USD","MSFD","LU0314106906.USD","LU0048584097.USD","LU1267930813.SGD","LU1935043536.SGD","LU2244417387.USD","LU1235295455.SGD","LU2148611432.USD","LU0823417653.USD","LU2361044949.HKD","BK4528","LU2360107325.USD","SGXZ23171101.USD","IE0002270589.USD","LU1236620834.HKD","LU1582987597.SGD","LU2264538146.SGD","LU0345774391.USD","LU2413666426.HKD","LU2505996509.AUD","IE00BDCRKT87.USD","LU2404859741.USD","SG9999004303.SGD","LU0965509101.SGD","LU2097344357.USD","LU2237443622.USD","BK4527","LU0203345920.USD","TSLS","LU0980610538.SGD","SG9999000418.SGD","LU0994945656.USD","BK4516","LU1868836914.USD","LU2106854487.HKD","LU1146622755.USD","TSII","LU1242518857.USD","LU1791710582.SGD","LU2462157665.USD","LU2764262908.HKD","LU2108987350.USD","IE00B7KXQ091.USD","LU1923623000.USD","IE000ITXATA3.USD","LU0266013472.USD","BK0072","LU1988902786.USD","IE00BN8TJ469.HKD","LU0096362180.USD","LU1983260115.SGD","LU2361044865.SGD","LU1712237335.SGD","LU2089284900.SGD","LU1934455863.HKD","SG9999018857.SGD","LU1582987324.SGD","LU2456880835.USD","LU1633808545.USD","LU0795875169.SGD","LU0426417589.USD","LU2211815571.USD","LU2237443978.SGD","LU0456855351.SGD","LU1861559042.SGD","LU2023250504.SGD","IE00B5TLWC47.USD","LU2413666699.HKD","LU2491049909.HKD","BK4534","BK4578","LU1116320901.HKD","LU1969619763.USD","LU1145028129.USD","LU1629891620.HKD","LU1861220033.SGD","LU1992135399.USD","IE00BWXC8680.SGD","LU1815333072.USD","LU0314104364.USD","LU1670711040.USD","IE00BHPRN162.USD","LU0345770308.USD","LU1061106388.HKD","LU2242650005.HKD","LU0256863811.USD","LU0528227936.USD","SG9999015952.SGD","LU0957791311.USD","LU0545039389.USD","LU0964807845.USD","LU1064131003.USD","BK4574","IE00B19Z8W00.USD","LU1670628061.USD","BK4566","LU0234570918.USD","SG9999014880.SGD","LU1400636574.HKD","LU1057294990.SGD","LU1023059063.AUD","TLA","BK4568","LU0979878070.USD","LU1839511570.USD","LU1119994496.HKD","LU0081259029.USD","LU1366192091.USD","LU1642822529.SGD","TSLO","GB00B4LPDJ14.GBP","MSFY","MSFL","LU0861579265.USD","LU2289578879.USD","LU2506952170.USD","LU0894486033.HKD","BK4555","LU0251132253.USD","TSLP","LU2087621335.USD","LU1868836757.USD","LU1674673428.USD","LU1066051811.HKD","SGXZ31699556.SGD","LU2077746001.SGD","LU0203347892.USD","LU0312595415.SGD","LU2275660780.HKD","BK4548","LU2471134879.HKD","LU0871640123.AUD","IE00B3S45H60.SGD","LU1935042488.USD","LU0823421333.USD","LU0124676726.USD","LU1582986359.USD","LU2191332357.HKD","IE000KEQY171.SGD","LU2125909247.SGD","SG9999014898.SGD","LU0096364046.USD","LU2092627202.USD","LU0077335932.USD","LU0683595622.HKD","LU0683600562.USD","IE000W1ABFV2.USD","LU0894485498.HKD","LU2272731865.HKD","LU0965509010.AUD","LU1674673691.USD","LU2357305700.SGD","LU0323591593.USD","LU1989764664.SGD","BK4504","LU0784383803.USD","LU2360032135.SGD","LU1242518931.SGD","BK0155","LU2404859667.USD","IE00BN29S564.USD","LU2097344431.USD","LU2580892789.USD","IE00B775H168.HKD","LU1196500208.SGD","LU2381873111.SGD","LU0985489474.SGD","BK4533","LU1121112475.USD","TSLT","BK0070","IE00BKPKM429.USD","LU1861215975.USD","LU1868837300.USD","LU1670627923.USD","LU2552382132.HKD","BK4612","BK4588","LU1153585028.USD","LU2112291526.USD","LU0127658192.USD","BK4503","LU0061474960.USD","LU0345769128.USD","LU1127390331.HKD","LU0354030438.USD","IE0004445239.USD","LU0433182093.SGD","BK4598","BK4525","BK0264","LU1228905037.USD","LU0323240290.USD","LU0879622024.SGD","LU2028103732.USD","LU2361045086.USD","LU0889566641.SGD","LU0823434740.USD","LU1551013425.SGD","LU0225283273.USD","LU2111349929.HKD","BK4535","BRK.A","LU1496350502.SGD","TSLR","LU0310799852.SGD","LU0320765992.SGD","LU2860962120.EUR","LU1043141123.HKD","LU2362541273.HKD","IE0004091025.USD","LU2473716301.USD","IE00BK4W5M84.HKD","IE0005OL40V9.USD","LU0068578508.USD","LU0187121727.USD","LU2298321311.HKD","SG9999015358.SGD","LU2750360641.GBP","SG9999002224.SGD","LU0708995401.HKD","BK4579","HK0000914660.USD","LU1623119135.USD","LU0345768740.USD","TSL","LU2506952097.USD","LU2054465674.USD","LU0960925559.SGD","CRSH","LU2430703251.USD","BK4577","LU1244550221.USD","LU0444973449.USD","LU1064131342.USD","LU1340139317.AUD","IE0009G5SDU7.USD","LU2210150020.SGD","LU0080751232.USD","LU0061474705.USD","LU1720051017.SGD","LU1989772923.USD","LU0094547139.USD","LU1035773651.USD","LU0107464264.USD","LU0276348264.USD","IE00B3SWFQ91.USD","LU2087625088.SGD","LU2362540622.SGD","LU1564329032.USD","LU1781817850.SGD","LU2237438978.USD","LU0122379950.USD","LU1951198990.SGD","TSYY","TSLG","LU0106261372.USD","LU0353189680.USD","BK0183","IE0034235295.USD","IE00BLSP4239.USD","SG9999015945.SGD","LU0950375773.USD","LU0211331839.USD","SG9999001424.SGD","LU2430703178.SGD","LU2324357040.USD","LU1181866309.USD","LU1861558580.USD","LU0210528500.USD","LU0109394709.USD","LU0320765489.SGD","LU2663582299.SGD","LU1496350171.SGD","LU1267930730.SGD","LU1935042991.SGD","LU2242649171.HKD","LU1430594728.SGD","BK4511","IE00BDRTCR15.USD","IE00BJTD4N35.SGD","LU1732799900.SGD","LU1989772840.SGD","LU2023251221.USD","LU1571399168.USD","LU2133065610.SGD","BK0169","LU1435385759.SGD","SG9999018865.SGD","BK4077","LU1236620750.USD","LU1934455194.USD","LU2461242641.AUD","LU2322448791.USD","TSLI","LU1868836591.USD","TSLY","LU2210149790.SGD","BK4532","LU2360108059.USD","LU1066051498.USD","LU0211327993.USD","LU1697837992.HKD","SG9999001077.SGD","IE0009356076.USD","LU2756315318.SGD","LU0097036916.USD","LU2458330243.SGD","LU2452424414.USD","LU1069344957.HKD","LU1564329628.SGD","LU1548497426.USD","IE00BZ1G4Q59.USD","LU2272731782.SGD","LU0494093205.USD","LU0302445910.USD","LU0757359368.USD","LU1699723380.USD","LU1732800096.USD","LU2487616109.SGD","TEST","IE00BQXX3F31.USD","BK4576","LU0417517546.SGD","LU1334329650.SGD","LU2095319765.USD","LU2092937221.SGD","IE00BBT3K403.USD","LU0210536198.USD","IE00B19Z9505.USD","IE00BKDWB100.SGD","GB00BDT5M118.USD","SG9999015341.SGD","BK4604","IE00BLSP4452.SGD","LU1791710400.SGD","LU2237443895.HKD","LU0342679015.USD","LU0985320562.USD","LU1064130708.USD","LU1814569148.SGD","LU0289961442.SGD","LU1035775433.USD","LU1046421795.USD","LU1228905540.USD","LU2272731600.USD","LU0708994859.HKD","LU2237443382.USD","LU1235294995.USD","LU1914381329.SGD","IE0034235303.USD","TSDD","LU1508157978.USD","LU1400636491.USD","IE00BSNM7G36.USD","LU0109391861.USD","LU2168564149.EUR","LU1951200564.SGD","LU0057025933.USD","LU2089283258.USD","LU1804176565.USD","LU1116320737.USD","LU1244550577.SGD","LU1935042215.USD","LU0823421416.USD","LU0878866978.SGD","MSFU","LU1861214812.USD","LU0476273544.USD","LU0320765059.SGD","LU1201861249.SGD","IE00B19Z8X17.USD","LU0058720904.USD","LU0724617625.USD","LU1803068623.USD","LU2505996681.GBP","LU2468319806.SGD","LU2065170008.USD","SG9999015986.USD","LU1720051108.HKD","LU0784385840.USD","LU1316542783.SGD","IE0034235188.USD","LU1232071149.USD","LU1066053197.SGD","07766","LU0210533765.USD","IE00BFSS8Q28.SGD","MSFO","LU0390134368.USD","LU0289739699.SGD","LU2420271590.USD","LU0130102774.USD","BK4592","LU0072462426.USD","LU2168564222.USD","IE00BMPRXN33.USD","LU0345770993.USD","LU2552382058.USD","LU1992135472.HKD","LU2543165471.USD","TSLA","LU0082616367.USD","LU0323239441.USD","LU1820825898.SGD","LU0690374615.EUR","LU2168563687.JPY","GB00B4QBRK32.GBP","BK4554","LU0820561818.USD","LU0198837287.USD","LU0203201768.USD","IE00BFXG0V08.USD","LU0095938881.EUR","LU0114720955.EUR","LU2265009873.SGD","IE00BYQQ9H92.USD","LU1280957306.USD","LU2458330169.SGD","LU2495084118.USD","LU0215105999.USD","IE00BKVL7J92.USD","LU2290526834.HKD","LU2764263203.CNY","IE0003U64NQ7.SGD","LU0256863902.USD","IE00BQXX3D17.EUR","LU0162691827.USD","LU0345769631.USD","LU1506573853.SGD","SG9999014575.USD","LU0289941410.SGD","IE00BJJMRY28.SGD","LU0889565916.HKD","LU2896262040.SGD","LU1564329115.USD","LU1202635105.USD","LU2271345857.HKD","LU1267930573.SGD","LU0175139822.USD","LU1244550494.USD","LU1221951046.USD","IE00BMPRXQ63.HKD","BK4567","LU2213496289.HKD","LU2249611893.SGD","LU2756315664.SGD","LU0882574139.USD","LU2347655073.USD","LU1084165304.USD","LU1852331112.SGD","BK4538","BK4524","LU0792757196.USD","LU1861127337.USD","LU0661504455.SGD","LU2322448957.HKD","LU0211328371.USD","LU2092937148.SGD","LU1917777945.USD","LU0238689110.USD","LU2433249047.HKD","LU1037948897.HKD","IE00BMPRXR70.SGD","LU2083900584.USD","LU2720916845.USD","LU2041044095.USD","LU2506951958.HKD","LU0820562030.AUD","LU2236285917.USD","LU0426412945.USD","IE00BQXX3C00.GBP","LU1670756490.USD","LU0029864427.USD","LU0072461881.USD","LU0234572021.USD","LU1997244956.HKD","IE00BK4W5L77.USD","LU1564329461.SGD","LU1585245621.USD","IE00BJTD4V19.USD","LU2097829019.USD","LU2471134523.USD","LU2023250330.USD","IE000YTNTUN2.SGD","LU0690374961.EUR","LU1645745479.HKD","LU1868837136.USD","LU0823434583.USD","BK0188","LU0070217475.USD","LU2148510915.USD","LU1670710588.SGD","LU0354030511.USD","LU0786609619.USD","LU0208291251.USD","SG9999015978.USD","IE00B775SV38.USD","LU2506951875.HKD","SG9999002232.USD","LU0784385170.HKD","IE00BJLML261.HKD","LU2237443549.SGD","IE00B19Z3581.USD","BK4550","IE00B4YYXB79.USD","LU1400636657.SGD","LU2580892862.HKD","LU1580142542.USD","LU0823417737.USD","LU0310800379.SGD","LU0472753341.HKD","LU0069063385.USD","LU0757359954.USD","BK0014","LU1066051225.USD","LU0128525929.USD","LU0444971666.USD","LU0648001328.SGD","LU2360107168.USD","LU1989773731.SGD","TSLQ","LU0823411888.USD","BK4551","IE00B7SZLL34.SGD","LU0170899867.USD","LU0738911758.USD","LU0965509283.SGD","SG9999014567.USD","LU1323610961.USD","LU1032466523.USD","LU2602419157.SGD","BK4581","LU0889565833.HKD","LU2592432038.USD","LU1778281490.HKD","LU0006306889.USD","SGXZ51526630.SGD","LU2237957902.USD","LU0949170772.SGD","LU0912757837.SGD","LU0957808578.USD","LU1861219969.SGD","LU1429558221.USD","LU2065171402.SGD","LU0265550359.USD","BK4585","LU1670711123.USD","LU2063271972.USD","LU1267930490.SGD","LU2279689827.SGD","GILD","LU0353189763.USD","LU2471134952.CNY","IE00B4JS1V06.HKD","LU0823414478.USD","LU0689626769.HKD","LU1691799644.USD","LU0289739343.SGD","LU0633140560.USD","LU2491050154.USD","LU0345774631.USD","LU2237957811.SGD","IE00BFSS7M15.SGD","LU0795875086.SGD","BK4507","LU2023250843.SGD","LU0265550946.USD","LU1074936037.SGD","TESL","TSLW","LU0158827781.USD","LU2552382215.SGD","BK4543","LU2168564065.EUR","LU0719512351.SGD","LU0689472784.USD","LU0726765562.USD","LU1935043023.USD","HK0000914686.HKD","LU1551013342.USD","LU0787776722.HKD","LU2430703095.HKD","LU0316494557.USD","LU1069347547.HKD","LU1803068979.SGD","LU2089984988.USD","LU0070302665.USD","LU1188199696.SGD","LU1043141396.HKD","LU2471134796.USD","LU2326559502.SGD","LU0267386448.USD","LU2237443465.HKD","LU0784384876.USD","LU0640476718.USD","LU2328871848.SGD","IE00B3T34201.USD","LU0345768153.USD","LU1718418525.SGD","LU2125909593.SGD","LU1221951129.SGD","TSLL","LU0868494617.USD","LU1989763005.USD","SG9999014542.SGD","SG9999014906.USD","IE00BYXW3230.USD","IE00B1XK9C88.USD","LU2247934214.USD","MSFW","LU0149725797.USD","LU2417539215.USD","LU1815336760.USD","IE0001KFT4U8.USD","LU0109392836.USD","LU1059921491.USD","LU0308772762.SGD","BK0196","IE00B5949003.HKD","LU0553294199.USD","LU0466842654.USD","LU0557290698.USD","SG9999017495.SGD","SGXZ99366536.SGD","LU2347655156.SGD","LU2065171311.SGD","LU0511384066.AUD","LU1823568750.SGD","LU0642271901.SGD","LU1582986433.USD","IE00BJJMRX11.SGD","LU1366333091.USD","SG9999014559.SGD","IE00B19Z3B42.SGD","LU0633140727.USD","LU0011850046.USD","EVS.SI","BK4139","LU0154236417.USD","LU0289960550.SGD","SGXZ81514606.USD","LU0157215616.USD","IE0004086264.USD","LU1489326972.SGD","LU0158827948.USD","LU0943347566.SGD","IE00B1BXHZ80.USD","LU0672654240.SGD","LU1301847155.USD","LU2491050071.SGD","LU0788109477.HKD","LU0882574055.USD","LU1261432733.SGD","LU2317271919.USD","LU2250418816.HKD","LU1997245094.SGD","LU2362541513.USD","LU1003077747.HKD","LU2360106780.USD","LU2403377893.USD","LU2750360997.AUD","LU2746668461.USD","LU0053666078.USD","LU0820561909.HKD","BK4583","LU0823416689.USD","LU0203202063.USD","LU1923622614.USD","LU1670710661.SGD","LU1997245177.USD","LU0949170426.SGD","LU2463028550.USD","LU0171293334.USD","LU1032955483.USD","LU2764263039.SGD","LU2125154935.USD","LU2168564495.EUR","MSFX","BK4097"],"gpt_icon":1}],"pageSize":20,"totalPage":17,"pageCount":6,"totalSize":336,"code":"91000000","status":"200"}]}}